Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer
Universitätsbibliothek Tübingen · 20.02.2023
DOI: 10.15496/publikation-78020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Universitätsbibliothek Tübingen, erschienen am 20.02.2023. Verfasst von Ji und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Breast cancer remains the leading malignancy in women around the world. Since over two thirds of breast cancers are estrogen receptor-α (ER-α) positive and higher incidence is found in postmenopausal women, endocrine therapy is the mainstay of adjunctive therapy for this population. However, resistance with longer treatment has aroused wide concern and is not yet fully understood. Progesterone receptor membrane component 1 (PGRMC1) as an upregulated membrane bound protein in tumorigenesis and progression has been reported to correlate with higher incidence of endocrine resistance. Thus, a better understanding of how PGRMC1 is involved in this process could help to stratify patients and guide decision making. The present study was undertaken to evaluate the impact of PGRMC1 overexpression (1) on the regulation of cell proliferation by 17-β estradiol (E2) and progestogens; (2) on the response to tamoxifen (TAM) treatment; (3) on the regulation of ER-α, progesterone receptor (PR) and intrinsic PGRMC1 expression by E2 and progestogens so as to discover the possible correlation between PGRMC1 and sexual hormone signaling pathways in breast cancer, as well as to investigate a tentative role of PGRMC1 in endocrine resistance. The present study was undertaken in empty vector or PGRMC1 transfected estrogen receptor (ER) positive breast cancer cells, ie. MCF-7ECV, T47DEVC, MCF-7WT12, and T47DWT3 cells. Cells were incubated with single E2 or progestogens, and with TAM plus E2 for 5 days. Progestogens used in the present study included progesterone (P4), medroxyprogesterone acetate (MPA) and norethisterone (NET). E2 was used at 10-9 M, and other agents were used at 10-7 M and 10-6 M. Cell proliferation was measured by Methyl thiazoletetrazolium (MTT) test. Expressions of ER-α, PR and PGRMC1 were measured by western blot. SPSS statistical software 23.0 was used for quantitative analysis. Multi-group comparison was carried out using ANVOA followed by Bonferroni test. P
Schlagwörter
Zitieren
APA
Ji, & Wenling (2023). Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer. Universitätsbibliothek Tübingen. https://doi.org/10.15496/publikation-78020
Vancouver
Ji, Wenling. Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer. Universitätsbibliothek Tübingen. 2023. doi:10.15496/publikation-78020
BibTeX
@article{Ji2023,
author = {Ji and Wenling},
title = {Progesterone Receptor Membrane Component 1 Promotes Cell Proliferation and Tamoxifen Resistance through Alteration of Sexual Receptors in Breast Cancer},
journal = {Universitätsbibliothek Tübingen},
year = {2023},
doi = {10.15496/publikation-78020}
}
EUVIMED